Year

2014

Status

Active

Team

Field

Cardiovascular therapeutic

Location

Nijmegen (The Netherlands)

Fund

BGV II

Staten Biotechnology

Staten Biotechnology aims to develop novel and innovative strategies for the treatment of dyslipidemia.